
Layla D. Berry
Examiner (ID: 16889, Phone: (571)272-9572 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1609, 1623, 1693 |
| Total Applications | 1713 |
| Issued Applications | 1092 |
| Pending Applications | 106 |
| Abandoned Applications | 561 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13955389
[patent_doc_number] => 20190054038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => NITRIC OXIDE GENERATING FORMULATIONS AND KITS
[patent_app_type] => utility
[patent_app_number] => 16/079934
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079934
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079934 | NITRIC OXIDE GENERATING FORMULATIONS AND KITS | Feb 22, 2017 | Abandoned |
Array
(
[id] => 16915802
[patent_doc_number] => 20210188894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => ARTIFICIAL NUCLEOSIDE AND ARTIFICIAL NUCLEOTIDE, AND ARTIFICIAL OLIGONUCLEOTIDE
[patent_app_type] => utility
[patent_app_number] => 16/077969
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 558
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077969 | Artificial nucleoside and artificial nucleotide, and artificial oligonucleotide | Feb 16, 2017 | Issued |
Array
(
[id] => 13702783
[patent_doc_number] => 20170362346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLES
[patent_app_type] => utility
[patent_app_number] => 15/422096
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15422096
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/422096 | METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLES | Jan 31, 2017 | Abandoned |
Array
(
[id] => 15087311
[patent_doc_number] => 20190338466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => METHOD FOR PRODUCING REGENERATED CELLULOSE FIBERS FROM COTTON CONTAINING TEXTILE WASTE
[patent_app_type] => utility
[patent_app_number] => 16/074392
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074392 | METHOD FOR PRODUCING REGENERATED CELLULOSE FIBERS FROM COTTON CONTAINING TEXTILE WASTE | Jan 31, 2017 | Abandoned |
Array
(
[id] => 11836286
[patent_doc_number] => 20170218005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'COMPOSITIONS AND METHODS RELATED TO GENTAMICIN'
[patent_app_type] => utility
[patent_app_number] => 15/417698
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9279
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/417698 | COMPOSITIONS AND METHODS RELATED TO GENTAMICIN | Jan 26, 2017 | Abandoned |
Array
(
[id] => 13982657
[patent_doc_number] => 20190060486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Continuous Complexation of Active Pharmaceutical Ingredients
[patent_app_type] => utility
[patent_app_number] => 16/073469
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073469 | Continuous complexation of active pharmaceutical ingredients | Jan 26, 2017 | Issued |
Array
(
[id] => 11588384
[patent_doc_number] => 20170112796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'METHOD OF SYNTHESISING SULFORAPHANE'
[patent_app_type] => utility
[patent_app_number] => 15/392370
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8229
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15392370
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/392370 | Method of synthesising sulforaphane | Dec 27, 2016 | Issued |
Array
(
[id] => 14029555
[patent_doc_number] => 10226509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Lymphangiogenesis inhibitors for cancer and for graft survival
[patent_app_type] => utility
[patent_app_number] => 15/389509
[patent_app_country] => US
[patent_app_date] => 2016-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 127
[patent_no_of_words] => 20867
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15389509
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/389509 | Lymphangiogenesis inhibitors for cancer and for graft survival | Dec 22, 2016 | Issued |
Array
(
[id] => 16915801
[patent_doc_number] => 20210188893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => CRYSTALLINE FORM OF GEMCITABINE
[patent_app_type] => utility
[patent_app_number] => 16/065369
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065369 | Crystalline form of gemcitabine | Dec 20, 2016 | Issued |
Array
(
[id] => 13118109
[patent_doc_number] => 10077399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-18
[patent_title] => Water-soluble fluorescence compound and method for preparing the same
[patent_app_type] => utility
[patent_app_number] => 15/384241
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4898
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15384241
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/384241 | Water-soluble fluorescence compound and method for preparing the same | Dec 18, 2016 | Issued |
Array
(
[id] => 13778105
[patent_doc_number] => 20190002591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => ACYLATION OF BIOPOLYMER COMPRISING ANHYDROGLUCOSE UNITS
[patent_app_type] => utility
[patent_app_number] => 16/064830
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064830
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064830 | ACYLATION OF BIOPOLYMER COMPRISING ANHYDROGLUCOSE UNITS | Dec 18, 2016 | Abandoned |
Array
(
[id] => 18117618
[patent_doc_number] => 11549000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Cellular glycosaminoglycan compositions and methods of making and using
[patent_app_type] => utility
[patent_app_number] => 16/063670
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 29921
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063670
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063670 | Cellular glycosaminoglycan compositions and methods of making and using | Dec 15, 2016 | Issued |
Array
(
[id] => 16125929
[patent_doc_number] => 10696705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Crystalline forms of LNT
[patent_app_type] => utility
[patent_app_number] => 16/063367
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4759
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063367
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063367 | Crystalline forms of LNT | Dec 15, 2016 | Issued |
Array
(
[id] => 11750356
[patent_doc_number] => 09708358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Massive parallel method for decoding DNA and RNA'
[patent_app_type] => utility
[patent_app_number] => 15/380284
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15386
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380284
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380284 | Massive parallel method for decoding DNA and RNA | Dec 14, 2016 | Issued |
Array
(
[id] => 11750356
[patent_doc_number] => 09708358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Massive parallel method for decoding DNA and RNA'
[patent_app_type] => utility
[patent_app_number] => 15/380284
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15386
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380284
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380284 | Massive parallel method for decoding DNA and RNA | Dec 14, 2016 | Issued |
Array
(
[id] => 14639065
[patent_doc_number] => 10364265
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-07-30
[patent_title] => Anhydrosugar synthesis
[patent_app_type] => utility
[patent_app_number] => 15/380030
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 8156
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380030
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380030 | Anhydrosugar synthesis | Dec 14, 2016 | Issued |
Array
(
[id] => 11528598
[patent_doc_number] => 20170088575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA'
[patent_app_type] => utility
[patent_app_number] => 15/380270
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15168
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380270
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380270 | Massive parallel method for decoding DNA and RNA | Dec 14, 2016 | Issued |
Array
(
[id] => 11815196
[patent_doc_number] => 09719139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Massive parallel method for decoding DNA and RNA'
[patent_app_type] => utility
[patent_app_number] => 15/380311
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15377
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380311 | Massive parallel method for decoding DNA and RNA | Dec 14, 2016 | Issued |
Array
(
[id] => 11750356
[patent_doc_number] => 09708358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Massive parallel method for decoding DNA and RNA'
[patent_app_type] => utility
[patent_app_number] => 15/380284
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15386
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380284
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380284 | Massive parallel method for decoding DNA and RNA | Dec 14, 2016 | Issued |
Array
(
[id] => 13622235
[patent_doc_number] => 20180362669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => METHOD FOR MANUFACTURING CELLOOLIGOSACCHARIDE
[patent_app_type] => utility
[patent_app_number] => 15/779986
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779986 | METHOD FOR MANUFACTURING CELLOOLIGOSACCHARIDE | Dec 13, 2016 | Abandoned |